A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DESTINY-PANTUMOUR04
- Status
- RECRUITING
- Phase
- N/A
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management
- Status
- RECRUITING
- Phase
- NA
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
- Status
- RECRUITING
- Phase
- PHASE1
177LuPSMA in Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
IDOV-Immune for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
- Status
- SUSPENDED
- Phase
- PHASE2
Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
- Status
- TERMINATED
- Phase
- PHASE1